所有阿根廷公司從事某一行業的公司：醫藥：專業
下面的清單包含在同一產業醫藥：專業下運作的所有阿根廷公司。該清單有助於追蹤他們的績效、損益表等。按任何必要的指標排序，它可以顯示行業中最昂貴的股票，例如：ASTRAZENECA PLC CEDEAR EACH REP 0.5 ADR USD0.25或具有最佳價格動態的股票，例如：JOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS)，從而有助於設計任何焦點的策略。
商品代碼 | 市值 | 價格 | 漲跌 % | 成交量 | 相對成交量 | P/E | 攤薄每股收益 TTM | 每股收益緩慢成長 TTM年增率 | 股息殖利率 % TTM | 部門 | 分析師評級 |
|---|---|---|---|---|---|---|---|---|---|---|---|
 LLYELI LILLY AND COMPANY CEDEAR EACH 56 REP 1DR | 792.19 T ARS | 15,400 ARS | −0.96% | 584 | 0.10 | 73.12 | 210.62 ARS | +235.69% | 0.38% | 健康科技 | — |
| LLYDELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 (USD) DR | 792.19 T ARS | 14.00 USD | +2.19% | 73 | 0.14 | 71.32 | 210.62 ARS | +167.86% | 0.38% | 健康科技 | — |
 JNJJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHSDR | 417.26 T ARS | 11,850 ARS | −1.04% | 678 | 0.07 | 19.84 | 597.27 ARS | +206.49% | 1.75% | 健康科技 | — |
| DJNJ3JOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS) DR | 417.26 T ARS | 1,350 ARS | +3.85% | 6 | 1.11 | — | — | — | — | 健康科技 | — |
| JNJDJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS(USD) DR | 417.26 T ARS | 10.55 USD | −0.47% | 337 | 0.73 | 18.95 | 597.27 ARS | +144.56% | 1.75% | 健康科技 | — |
| DJN3DJOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS) DR | 417.26 T ARS | 1.300 USD | 0.00% | 2 | 0.00 | — | — | — | — | 健康科技 | — |
 ABBVABBVIE INC CEDEAR EACH 10 REPR 1 COMDR | 365.17 T ARS | 21,475 ARS | +0.23% | 408 | 0.25 | 9.54 | 2,251.52 ARS | +58.86% | 2.34% | 健康科技 | — |
| ABBVDABBVIE INC CEDEAR EA 10 REP 1 COM(USD) DR | 365.17 T ARS | 18.40 USD | 0.00% | 5 | 0.06 | 8.77 | 2,251.52 ARS | +26.76% | 2.34% | 健康科技 | — |
 AZNASTRAZENECA PLC CEDEAR EACH REP 0.5 ADR USD0.25DR | 231.59 T ARS | 38,775 ARS | −0.32% | 146 | 0.22 | 39.68 | 977.22 ARS | +146.53% | 1.80% | 健康科技 | — |
| AZNDASTRAZENECA PLC CEDEAR EA RE 0.5 ADR (USD) DR | 231.59 T ARS | 34.15 USD | −4.48% | 20 | 0.82 | 37.50 | 977.22 ARS | +96.72% | 1.80% | 健康科技 | — |
 NVSNOVARTIS AG CEDEAR EACH 4 REP 1DR | 231.3 T ARS | 31,325 ARS | −1.73% | 37 | 0.20 | 4.56 | 6,872.32 ARS | +10.89% | 3.84% | 健康科技 | — |
| NVSDNOVARTIS AG CEDEAR EAC 4 REP 1(USD) DR | 231.3 T ARS | 26.20 USD | −1.13% | 4 | 0.75 | 4.09 | 6,872.32 ARS | −11.51% | 3.84% | 健康科技 | — |
 MRKMERCK & CO INC CEDEAR (5 REP 1 USD0.50)DR | 216.89 T ARS | 17,775 ARS | −0.84% | 137 | 0.07 | 13.34 | 1,332.07 ARS | +380.66% | 2.24% | 健康科技 | — |
| MRKDMERCK & CO INC CEDEAR EAC 5 RE 1 (USD) DR | 216.89 T ARS | 15.80 USD | +1.94% | 10 | 0.09 | 12.73 | 1,332.07 ARS | +283.54% | 2.24% | 健康科技 | — |
 PFEPFIZER INC CEDEAR EACH 4 REP 1 ORD USD0.05DR | 145.26 T ARS | 6,420 ARS | −3.46% | 3.61 K | 0.22 | 18.86 | 340.44 ARS | +754.74% | 4.06% | 健康科技 | — |
| PFEDPFIZER INC CEDEAR 4 REP 1 ORD USD0.05(USD) DR | 145.26 T ARS | 5.70 USD | −4.20% | 216 | 0.08 | 17.96 | 340.44 ARS | +582.03% | 4.06% | 健康科技 | — |
| PFECPFIZER INC CEDEAR EACH 2 REP 1 ORD USD0.05 DR | 145.26 T ARS | 5.95 USD | −4.03% | 12 | 0.06 | 18.75 | 340.44 ARS | +582.03% | 4.06% | 健康科技 | — |
 BMYBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1DR | 106.12 T ARS | 17,850 ARS | −1.24% | 156 | 0.27 | 20.59 | 866.77 ARS | — | 3.73% | 健康科技 | — |
 GSKGSK PLC CEDEAR EACH REPR 1/4 ADRDR | 81.28 T ARS | 10,575 ARS | −0.24% | 2 | 0.00 | 22.25 | 475.21 ARS | +66.14% | 3.17% | 健康科技 | — |
| GSKDGSK PLC CEDEAR EACH REPR 1/4 ADR (USD) DR | 81.28 T ARS | 9.42 USD | −6.27% | 61 | 0.88 | 21.27 | 475.21 ARS | +32.57% | 3.17% | 健康科技 | — |
 BIIBBIOGEN INC CEDEAR EACH 13 REP 1 COM USD0.0005DR | 19.3 T ARS | 10,575 ARS | 0.00% | 309 | 0.58 | 14.32 | 738.48 ARS | +152.73% | 0.00% | 健康科技 | — |
| BIIBDBIOGEN INC CEDEAR EAC 13 RE 1 COM(USD) DR | 19.3 T ARS | 9.20 USD | −6.12% | 10 | 0.55 | 13.37 | 738.48 ARS | +101.66% | 0.00% | 健康科技 | — |
 RICHLABORATORIOS RICHMOND SACIF | 113.86 B ARS | 1,430 ARS | +1.42% | 640 | 0.04 | 5.44 | 262.78 ARS | — | 0.00% | 健康科技 | — |
 ROSEINSTITUTO ROSENBUCH SA DE BIOLOGIA | 3.72 B ARS | 86.0 ARS | −1.60% | 1 K | 0.13 | 20.15 | 4.27 ARS | +64.50% | 0.00% | 健康科技 | — |